EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Low anterior resection syndrome

Seung-Bum Ryoo iD

Annals of Gastroenterological Surgery · 2023-09 · 7 (5) · 719-724

DOI: 10.1002/ags3.12695 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Annals of Gastroenterological Surgery, online erschienen am 23.05.2023. Verfasst von Seung-Bum Ryoo. Beteiligte Einrichtung: Division of Colorectal Surgery, Department of Surgery Seoul National University Hospital, Seoul National University College of Medicine Seoul Korea. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Low anterior resection syndrome (LARS) is the distressful defecatory functional problem after sphincter‐saving surgery for rectal cancer. Although the symptoms of fecal urgency, frequency, and incontinence may develop in most of the patients after surgery, there is no definitive treatments for LARS. Multifactorial etiologies and various risk factors have been identified, but the reduction of storage capacity in the rectum is one of the main reasons for LARS. Anal sphincter muscle or nerve damage during rectoanal resection or anastomosis construction, and intersphincteric resection for low‐lying tumors or hand‐sewing anastomosis, are the absolute risk factors for LARS. Preoperative radiotherapy, postoperative complications, such as anastomosis leakage, or longer duration of stoma, are also risk factors. The severity of LARS can be confirmed using the LARS score questionnaire. The questionnaire has been translated to numerous language versions including Korean and have been validated. Diverse empirical treatments, such as loperamide, fiber, probiotics, or enema, have been tried, but the safety and efficacy have not been verified yet. The 5‐Hydroxytryptamine (5‐HT) receptor antagonist, ramosetron, used for diarrhea‐dominant irritable bowel syndrome, is one potential drug for relieving the symptoms of major LARS. A randomized‐controlled trial suggested the use of ramosetron could be safe and efficacious for patients who have major LARS after sphincter‐saving rectal cancer surgery. Novel techniques or drugs for relieving the symptoms of LARS should be developed more and further studies are necessary.

Schlagwörter

Stichwörter der Autor:innen

compliancedefecatory functionlow anterior resection syndromequality of liferectal cancer

Autor:innen und Institutionen

  • Division of Colorectal Surgery, Department of Surgery Seoul National University Hospital, Seoul National University College of Medicine Seoul Korea.
  • Colorectal Cancer Center Seoul National University Cancer Hospital Seoul Korea.

ORCID-Profile: Seung-Bum Ryoo

Zitieren

APA

Ryoo, S. B. (2023). Low anterior resection syndrome. Annals of Gastroenterological Surgery, 7(5), 719-724. https://doi.org/10.1002/ags3.12695

Vancouver

Ryoo SB. Low anterior resection syndrome. Annals of Gastroenterological Surgery. 2023;7(5):719-724. doi:10.1002/ags3.12695

BibTeX
@article{Ryoo2023,
  author = {Ryoo, Seung-Bum},
  title = {Low anterior resection syndrome},
  journal = {Annals of Gastroenterological Surgery},
  year = {2023},
  volume = {7},
  number = {5},
  pages = {719--724},
  doi = {10.1002/ags3.12695}
}
Kostenlos starten →